Weiss Asset Management’s Centessa Pharmaceuticals CNTA Stock Holding History

Weiss Asset Management’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-510,407	Closed	-$20.3M	–	677
2026 Q1	$20.3M	Buy	+510,407	New	+$13.1M	0.34%	60

Weiss Asset Management's CNTA Position: Q2 2026 in Review

Weiss Asset Management sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 510,407 shares — an estimated $20.3M sold.

Weiss Asset Management first reported a position in CNTA in Q1 2026 and held it in 1 quarter. The position peaked at $20.3M in Q1 2026. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

Weiss Asset Management reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Weiss Asset Management sold 510,407 Centessa Pharmaceuticals shares in Q2 2026, an estimated $20.3M.
Weiss Asset Management first reported a position in Centessa Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Weiss Asset Management's Centessa Pharmaceuticals position peaked at $20.3M in Q1 2026.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on Weiss Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.